Skip to main content
SpringerLink
Log in

Cost of Pharmacological Care of the Elderly

Implications for Healthcare Resources

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Expenditures on prescribed medicines are significantly higher among those aged 65 years and over than among younger people. As populations in developed countries age so the cost of pharmacological care associated with the older population can be expected to increase. While pharmacological care represents only one component of healthcare, its costs are increasing rapidly because of advances in technology and increasing use. However, such costs should be considered within a context of decreasing disability in the elderly population, improving economic conditions among seniors and the relationship of these costs with those in other aspects of healthcare. Where medications have been demonstrated to be cost-effective, attempts to curtail expenditure growth may prove a false economy resulting in significantly higher growth elsewhere such as in the hospital and long-term care sectors. Policy responses to this issue should encompass the inclusion of elderly patients in clinical trials, the use of evidence-based principles of practice and strategies to ensure that this population obtain maximum benefit from medication through education and counselling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1

Similar content being viewed by others

References

  1. Woloshin S, Schwartz LM, Tremmel J, et al. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet 2001; 358(9288): 1141–6

    Article  PubMed  CAS  Google Scholar 

  2. Zweifel P, Ferrari M. Is there a Sisyphus syndrome in health care? In: Zweifel P, Frech III HE, editors. Health economics worldwide. Amsterdam: Kluwer, 1992: 3111–330

    Chapter  Google Scholar 

  3. Anderson GF, Hussey PS. Population aging: a comparison among industrialized countries. Health Aff 2000; 19: 191–212

    Article  CAS  Google Scholar 

  4. United Nations. Demographic Yearbook, Series R. New York: (United Nations publication, Sales No. E/F.98.XIII.1) 1996

    Google Scholar 

  5. Metge C, Black C, Peterson S, et al. The population’s use of pharmaceuticals. Med Care 1999; 37(6): JS42–59

    Article  PubMed  CAS  Google Scholar 

  6. Mueller C, Schur C, O’Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health 1997; 87(10): 1626–9

    Article  PubMed  CAS  Google Scholar 

  7. Hoffman C, Rice D, Sung HY. Persons with chronic conditions, their prevalence and costs. JAMA 1996; 276(18): 1473–9

    Article  PubMed  CAS  Google Scholar 

  8. Skoll SL, August RL, Johnson GE. Drug prescribing for the elderly in Saskatchewan during 1976. CMAJ 1979; 121: 1074–81

    CAS  Google Scholar 

  9. Hale WE, May FE, Marks RG, et al. Drug use in an ambulatory elderly population: a five year update. Drug Intell Clin Pharm 1987; 21: 530–5

    PubMed  CAS  Google Scholar 

  10. Nolan L, O’Malley K. Patients, prescribing and benzodiazepines. Eur J Clin Pharmacol 1988; 35: 225–9

    Article  PubMed  CAS  Google Scholar 

  11. Kobayashi Y. Health care expenditures for the elderly and reforms in the health care system in Japan. Health Policy 1994; 29: 197–208

    Article  PubMed  CAS  Google Scholar 

  12. Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med Care 1999; 37: 926–36

    Article  PubMed  CAS  Google Scholar 

  13. Long SH. Prescription drugs and the elderly: issues and options. Health Aff 1994; 13: 157–74

    Article  CAS  Google Scholar 

  14. Freund DA, Willison D, Reeher G, et al. Outpatient pharmaceuticals and the elderly: policies in seven nations. Health Aff 2000; 19: 259–66

    Article  CAS  Google Scholar 

  15. Thomas CP, Ritter G, Wallack SS. Growth in prescription drug spending among insured elders. Health Aff 2001; 20: 265–77

    Article  CAS  Google Scholar 

  16. Heffler S, Levit K, Smith S, et al. Health spending growth up in 1999; faster growth expected in the future. Health Aff 2001; 20: 193–203

    Article  CAS  Google Scholar 

  17. Mehl B, Santell J. Projecting future drug expenditures-2001. Am J Health Syst Pharm 2001; 58: 1251–33

    Google Scholar 

  18. Anderson GM, Kerluke KJ, Pulcins IR, et al. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program. Inquiry 1993; 30: 199–207

    PubMed  CAS  Google Scholar 

  19. Bodenheimer TS. Affordable prescriptions for the elderly. JAMA 2001; 286: 1762–3

    Article  PubMed  CAS  Google Scholar 

  20. Pitkala KH, Valvanne J, Kulp S, et al. Secular trends in self-reported functioning, need for assistance and attitudes towards life: 10-year differences of three year older cohorts. J Am Geriatr Soc 2001; 49: 596–600

    Article  PubMed  CAS  Google Scholar 

  21. Liao Y, McGee DL, Cao G, et al. Quality of the last year of life of older adults: 1986 vs 1993. JAMA 2000; 283: 512–8

    Article  PubMed  CAS  Google Scholar 

  22. Manton KG, Corder LS, Stallard E. Monitoring changes in the health of the US elderly population: correlates with biomedical research and clinical innovations. FASEB J 1997; 11: 923–30

    PubMed  CAS  Google Scholar 

  23. Singer BH, Manton KG. The effects of heath changes on projections of health service needs for the elderly population of the United States. Proc Natl Acad Sci U S A 1998; 95: 15618–22

    Article  PubMed  CAS  Google Scholar 

  24. Worrall A, Rea JN, Ben-Shlomo Y. Counting the cost of social disadvantage in primary care: retrospective analysis of patient data. BMJ 1997; 314: 38–42

    Article  PubMed  CAS  Google Scholar 

  25. Malmstrom M, Johansson SE, Sundquist J. A hierarchical analysis of long-term illness and mortality in socially deprived areas. Soc Sci Med 2001; 53: 265–75

    Article  PubMed  CAS  Google Scholar 

  26. Crimmins EM, Saito Y. Trends in healthy life expectancy in the United States, 1970–1990: gender, racial and educational differences. Soc Sci Med 2001; 52: 1629–41

    Article  PubMed  CAS  Google Scholar 

  27. Perls TT, Wood ER. Acute care costs of the oldest old. Arch Intern Med 1996; 156: 754–60

    Article  PubMed  CAS  Google Scholar 

  28. Fries JF. Aging, natural death and the compression of morbidity. N Engl J Med 1980; 303: 130–5

    Article  PubMed  CAS  Google Scholar 

  29. Berndt ER, Cockburn IM, Cocks DL, et al. Prescription drug prices for the elderly. Mon Labor Rev 1998; 121: 23–34

    Google Scholar 

  30. McKercher PL. Pharmaceuticals in Medicare reform. Clin Ther 1997; 19: 1426–32

    Article  PubMed  CAS  Google Scholar 

  31. Fairman KA. The effect of new and continuing prescription drug use on cost: a longitudinal analysis of chronic and seasonal utilization. Clin Ther 2000; 22: 641–52

    Article  PubMed  CAS  Google Scholar 

  32. Abrams WB, Beers MH. Clinical pharmacology in an aging population. Clin Pharmacol Ther 1998; 63: 281–4

    Article  PubMed  CAS  Google Scholar 

  33. Adams AS, Soumerai SB, Ross-Degnan D. Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? Health Aff (Millwood) 2001; 20: 276–87

    Article  CAS  Google Scholar 

  34. Adams AS, Soumerai SB, Ross-Degnan D. The case for a Medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health 2000; 22: 49–61

    Article  Google Scholar 

  35. Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost sharing. Soc Sci Med 1985; 21: 1063–9

    Article  PubMed  CAS  Google Scholar 

  36. Aaronson WE, Zinn JS, Rosko MD. The success and repeal of the Medicare Catastrophic Coverage Act: a paradoxical lesson for health care reform. J Health Polit Policy Law 1994; 19: 753–71

    Article  PubMed  CAS  Google Scholar 

  37. AARP Facts. What is AARP? [online]. Available at URL: http://www.aarp.org. [Accessed 2002 Jul 15]

  38. Zweibel NR, Cassel CK, Karrison T. Public attitudes about the use of chronological age as a criterion for allocating health care resources. Gerontologist 1993; 33: 74–80

    Article  PubMed  CAS  Google Scholar 

  39. Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32

    Article  PubMed  CAS  Google Scholar 

  40. Shaw AB. Age as a basis for healthcare rationing: support for agist policies. Drugs Aging 1996; 9: 403–5

    Article  PubMed  CAS  Google Scholar 

  41. Scharf S, Flamer H, Christophidis N. Age as a basis for healthcare rationing: arguments against agism. Drugs Aging 1996; 9: 399–402

    Article  PubMed  CAS  Google Scholar 

  42. Department of Health. National service framework for older people. London: Department of Health, 2001

    Google Scholar 

  43. Crystal S, Johnson RW, Harman J, et al. Out-of-pocket health care costs among older Americans. J Gerontol B Psychol Sci Soc Sci 2000; 55B(1): S51–62

    Google Scholar 

  44. Steinberg EP, Gutierrez B, Momani A, et al. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Aff 2000; 19: 198–211

    Article  CAS  Google Scholar 

  45. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325: 1072–7

    Article  PubMed  CAS  Google Scholar 

  46. Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid: effect on therapy, cost, and equity. N Engl J Med 1987; 317: 550–6

    Article  PubMed  CAS  Google Scholar 

  47. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331: 650–5

    Article  PubMed  CAS  Google Scholar 

  48. Federman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA 2001; 286: 1732–9

    Article  PubMed  CAS  Google Scholar 

  49. Blustein J. Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Aff 2000; 19: 219–30

    Article  CAS  Google Scholar 

  50. Rogowski J, Lillard LA, Kington R. The financial burden of prescription drug use among elderly persons. Gerontologist 1997; 37: 475–82

    Article  PubMed  CAS  Google Scholar 

  51. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001; 285: 421–9

    Article  PubMed  CAS  Google Scholar 

  52. Walley T. Prescription charges: change overdue? BMJ 1998; 317: 487–8

    Article  PubMed  CAS  Google Scholar 

  53. Sias JJ, Bennett MS. A reimbursable education service for patients with hepatitis C. J Am Pharm Assoc 2001; 41(3): 448–53

    CAS  Google Scholar 

  54. Timmer JW, de Smet PA, Schuling J, et al. Patient education to users of oral hypoglycemic agents: the perspective of Dutch community pharmacists. Pharm World Sci 1999; 21(5): 200–4

    Article  PubMed  CAS  Google Scholar 

  55. Crealey GE, McElnay JC, Maguire TA, et al. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 1998; 14(3): 323–33

    Article  PubMed  CAS  Google Scholar 

  56. Shmucker DL, Vesell ES. Are the elderly under-represented in clinical drug trials? J Clin Pharmacol 1999; 39: 1103–8

    Google Scholar 

  57. Lapane KL, Hughes CM. Optimising drug utilisation in long term care. Pharmacoeconomics 2002; 20: 143–52

    Article  PubMed  Google Scholar 

  58. Gorham P. Cost-effectiveness guidelines: the experience of Australian manufacturers. Pharmacoeconomics 1995; 8: 369–73

    Article  PubMed  CAS  Google Scholar 

  59. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven european countries. Drugs Aging 2001; 18(1): 63–77

    Article  PubMed  CAS  Google Scholar 

  60. Carter BL, Malone DC, Valuck RJ, et al. The IMPROVE study: background and study design. Am J Health Syst Pharm 1998; 55: 62–7

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr O’Neill was supported during preparation of this manuscript by a Harkness Fellowship Grant from the Commonwealth Fund.

Dr Hughes was supported during the preparation of this manuscript by a National Primary Care Career Scientist Award from the Research and Development Office, Northern Ireland. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. School of Policy Studies, University of Ulster Jordanstown, Room 03A14, Shore Road, Newtownabbey, BT37 0QB, Northern Ireland, UK

    Ciaran O’Neill

  2. School of Pharmacy, Clinical and Practice Research Group, Queen’s University Belfast, Belfast, Northern Ireland, UK

    Carmel M. Hughes & Anna Schweizer

  3. Centre for Social Research, Queen’s University Belfast, Belfast, Northern Ireland, UK

    James Jamison

Authors
  1. Ciaran O’Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmel M. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Jamison
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Schweizer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ciaran O’Neill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Neill, C., Hughes, C.M., Jamison, J. et al. Cost of Pharmacological Care of the Elderly. Drugs Aging 20, 253–261 (2003). https://doi.org/10.2165/00002512-200320040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200320040-00002

Keywords

Search

Navigation